January 17, 2019

Hepatitis C Genotype 3 Treated with Shortened Glecapravir/Pibrentasvir

Analysis of data from phase 2 and 3 trials supports an HCV genotype 3 indication for glecaprevir/pibrentasvir, and confirms its efficacy over 8 weeks. An integrated […]
January 10, 2019

Screening For Hepatitis C Virus Lags At Drug Treatment Clinics

As the number of people who inject drugs and share needles has soared, the rate of infection with hep C has climbed, too. Yet many drug […]
January 8, 2019

What’s the Difference Between Hepatitis A, B, and C?

Did you know there are different types of hepatitis? The three most common are A, B, and C, each named for the specific virus that causes […]
January 3, 2019

 Hepatitis C Screening And New Treatments Allow Baby Boomers To Escape “The Kiss of Death”

Finding out you have stage 3 hepatitis C (HCV) might not be most people’s idea of luck, but Ron Shean feels fortunate. Despite the damage to […]
December 27, 2018

Hepatitis C Reinfection Rates Greater in Drug Users Despite DAAs

  Investigators also found that opiate agonist therapy could have a positive effect in limiting reinfection rates after patients achieve SVR. A population-based study of 1.7 […]
December 20, 2018

Hepatitis C and HIV: Risk, symptoms, prevention, and treatment

People living with HIV are at higher risk of contracting hepatitis C. This because HIV can weaken the immune system, leaving the body more vulnerable to […]
December 18, 2018

Earlier Hepatitis C Detection Could Enable Shorter Treatment

Successful 8-week treatment of newly diagnosed HCV genotype 1 adds to evidence that early detection could enable shorter, less costly treatments. Successful treatment of recently acquired hepatitis […]